Christine VOIGT

Person

Devon, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for reducing risk of onset of acute graft versus host disea...
- Patent number 11,857,610
- Issue date Jan 2, 2024
- CSL Behring L.L.C.
- Marc Uknis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Methods for Reducing Risk of Onset of Acute Graft Versus Host Disea...
- Publication number 20240238395
- Publication date Jul 18, 2024
- CSL BEHRING L.L.C.
- Marc UKNIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Treating Antibody-Mediated Rejection
- Publication number 20240000908
- Publication date Jan 4, 2024
- CSL BEHRING GMBH
- John Roberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEA...
- Publication number 20210008182
- Publication date Jan 14, 2021
- CSL BEHRING L.L.C.
- Marc UKNIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND...
- Publication number 20200115436
- Publication date Apr 16, 2020
- CSL Behring Lengnau AG
- Yanyan LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS
- Publication number 20200093901
- Publication date Mar 26, 2020
- CSL BEHRING LENGNAU AG
- Christine VOIGT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF...
- Publication number 20160346366
- Publication date Dec 1, 2016
- CSL Limited
- Iris JACOBS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Christine VOIGT

Person

Patents Grantslast 30 patents

Methods for reducing risk of onset of acute graft versus host disea...

Patents Applicationslast 30 patents

Methods for Reducing Risk of Onset of Acute Graft Versus Host Disea...

Method for Treating Antibody-Mediated Rejection

METHODS FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEA...

21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND...

SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS

FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF...